@article{ajmcr2021975,
author={{Umeh, Chukwuemeka A. and Kumar, Sabina and Carvalho, John and Arcuri, Christina and Ahaneku, Hycienth and Pulumati, Krishna and Shah, Shivang and Ma, Austin and Gupta, Rakesh},
title={Vancomycin Induced Thrombocytopenia Complicating Permanent Pacemaker Placement: A Case Report},
journal={American Journal of Medical Case Reports},
volume={9},
number={7},
pages={360--362},
year={2021},
url={http://pubs.sciepub.com/ajmcr/9/7/5},
issn={2374-216X},
abstract={Introduction: Vancomycin is widely used in patients with methicillin resistant staphylococcus aureus (MRSA) infections or with other infections unresponsive to other antibiotics. Vancomycin-related adverse effects, including nephrotoxicity, ototoxicity, red-man syndrome, and neutropenia have been reported. Vancomycin induced thrombocytopenia is a rare complication of vancomycin that many physicians are unaware of. When an acute decline in platelet count or bleeding occur in patients on vancomycin, vancomycin- induced thrombocytopenia should be considered. Case: We present a case of acute severe thrombocytopenia that occurred within 12 hours after vancomycin infusion in a patient that received permanent pacemaker placement. Vancomycin was discontinued and patient¡¯s platelets returned to baseline five days after vancomycin was discontinued. Conclusion: This case report highlights the importance of physicians being aware of vancomycin induced thrombocytopenia, a rare but reversible complication of vancomycin, which if diagnosed early will lead to early discontinuation of vancomycin, early resolution of thrombocytopenia and reduced hospital stay.},
doi={10.12691/ajmcr-9-7-5}
publisher={Science and Education Publishing}
}